Anthony J Furlan Selected Research

saruplase

5/2003	Factors influencing outcome and treatment effect in PROACT II.
1/2002	The role of recombinant pro-urokinase (r-pro-UK) and intra-arterial thrombolysis in acute ischaemic stroke: the PROACT trials. Prolyse in Acute Cerebral Thromboembolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anthony J Furlan Research Topics

Disease

38	Stroke (Strokes) 01/2022 - 01/2002
29	Ischemic Stroke 01/2022 - 01/2002
7	Patent Foramen Ovale 03/2016 - 12/2010
4	Transient Ischemic Attack 08/2014 - 12/2010
3	Paradoxical Embolism 12/2021 - 12/2010
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2018 - 03/2003
2	Infarction (Infarctions) 01/2018 - 08/2003
2	Myocardial Infarction 11/2017 - 04/2014
2	Cerebral Hemorrhage 01/2010 - 08/2003
2	Hypotension (Low Blood Pressure) 09/2003 - 08/2002
1	Aneurysm (Aneurysms) 12/2021
1	Hypertension (High Blood Pressure) 01/2015
1	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2014
1	Brain Infarction 12/2012
1	Pathologic Constriction (Stenosis) 06/2012
1	Neurologic Manifestations (Neurological Manifestations) 12/2010
1	Atrial Fibrillation 04/2010
1	Thrombosis (Thrombus) 06/2008
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2003
1	Hemorrhagic Stroke 09/2002
1	Brain Ischemia (Cerebral Ischemia) 08/2002
1	Wounds and Injuries (Trauma) 08/2002

Drug/Important Bio-Agent (IBA)

8	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 09/2002
5	Desmodus rotundus salivary plasminogen activator alpha 1IBA 09/2012 - 05/2006
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 05/2009
2	Neuroprotective AgentsIBA 12/2012 - 08/2003
2	saruplaseIBA 05/2003 - 01/2002
1	Clopidogrel (Plavix)FDA Link 01/2022
1	antineoplaston A10 (A 10)IBA 12/2021
1	LipidsIBA 11/2017
1	Antihypertensive Agents (Antihypertensives)IBA 11/2017
1	APTIBA 09/2015
1	AnticoagulantsIBA 09/2015
1	Blood Glucose (Blood Sugar)IBA 01/2015
1	Complement System Proteins (Complement)IBA 01/2014
1	Warfarin (Coumadin)FDA LinkGeneric 05/2009
1	Plasminogen Activators (Plasminogen Activator)IBA 02/2009
1	Abciximab (ReoPro)FDA Link 06/2008
1	Pharmaceutical PreparationsIBA 08/2005
1	Nitric Oxide Synthase (NO Synthase)IBA 09/2003
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 08/2003
1	Contrast MediaIBA 08/2003
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 08/2002
1	Carbon DioxideIBA 08/2002
1	Adenosine Diphosphate (ADP)IBA 08/2002
1	Heparin (Liquaemin)FDA LinkGeneric 06/2002

Therapy/Procedure

26	Therapeutics 12/2021 - 01/2002
9	Thrombectomy 01/2022 - 11/2009
3	Stents 01/2022 - 06/2008
2	Thrombolytic Therapy 08/2003 - 06/2002
1	Patient Care Bundles 01/2016
1	Secondary Prevention 09/2015
1	Combined Modality Therapy 12/2012
1	Catheter Ablation 04/2010
1	Time-to-Treatment 08/2003
1	Anesthesia 08/2002